Ampio Pharmaceuticals ( Ampio Pharmaceuticals)

Primary tabs

Ampio Pharmaceuticals's picture

Management

Contact Address

About Ampio Pharmaceuticals

Worldwide pharmaceutical sales are estimated to be more than $750 billion annually with significant opportunities for growth. Aging populations, expanded healthcare, declining R&D productivity and drug patent expirations have created increased demand for safe and effective drugs. Efforts to reduce health care costs have also heightened interest in new uses (‘indications’) for approved drugs and unique combination products using established drugs. This strategy accelerates development, reduces development costs and improves success rates because approved drugs typically have extensive human safety records.

Ampio Pharmaceuticals press release, blog etc

Wed, 04/27/2022 - 14:23 Ampio Pharmaceuticals, Inc. to Hold Conference Call
Wed, 03/09/2022 - 08:50 Ampio Pharmaceuticals to Participate at the 34th Annual Roth Conference
Thu, 02/10/2022 - 18:16 Ampio Expands Board of Directors with Addition of Elizabeth Varki Jobes
Wed, 01/05/2022 - 20:34 Ampio Pharmaceuticals Presents Corporate Overview at H.C. Wainwright Bioconnect Conference
Mon, 12/13/2021 - 19:47 AMPIO PHARMACEUTICALS ANNOUNCES PRICING OF $22.5 MILLION REGISTERED DIRECT OFFERING
Sun, 11/28/2021 - 23:52 Ampio Pharmaceuticals to Host Business Update Call with Chairman and CEO Mike Martino on Wednesday
Mon, 11/22/2021 - 19:16 Ampio Pharmaceuticals Announces Shareholder / Business Update Call with its CEO & Chairman, Michael Martino
Mon, 11/22/2021 - 17:03 Board Member Michael Martino to Become Interim Chairman and CEO of Ampio Pharmaceuticals, Mike Macaluso to Take Medical Leave
Tue, 09/21/2021 - 16:46 Ampio Pharmaceuticals Receives Approval from the Drugs Controller General of India (DCGI) to Commence AP-019 Phase II Study in India
Wed, 09/15/2021 - 15:07 Ampio Pharmaceuticals Announces Top-line Results from AP-013 Phase III Study of Ampion in Adult Patients Suffering from Severe Osteoarthritis of the Knee (OAK)
Fri, 08/13/2021 - 06:13 Ampio Pharmaceuticals Announces Important New Research Manuscript on Anti-Inflammatory Mode of Action
Thu, 08/12/2021 - 06:12 Ampio Pharmaceuticals Reminds Stockholders to Vote Shares in Advance of 2021 Annual Meeting
Wed, 08/11/2021 - 04:12 Ampio Pharmaceuticals to Participate in Upcoming Virtual Investor Conferences
Wed, 07/28/2021 - 08:18 Ampio Pharmaceuticals to Present at the 14th International Congress on Systemic Lupus Erythematosus (LUPUS 2021) & 6th International Congress on Controversies in Rheumatology and Autoimmunity (CORA)
Fri, 06/25/2021 - 06:42 Ampio Pharmaceuticals Announces Patient Randomization and Dosing in AP-019 Phase II Study of Inhaled Ampion in COVID-19 Respiratory Distress
Fri, 06/18/2021 - 07:12 Ampio Pharmaceuticals, Inc. to Join the Russell 2000 Index and Russell 3000 Index
Mon, 06/14/2021 - 09:42 Ampio Pharmaceuticals to Present at the 2021 International Society for Pharmaceutical Engineers Annual Meeting and Expo
Fri, 06/11/2021 - 08:18 Ampio Pharmaceuticals to Participate in the Alliance Global Partners Virtual Summer Healthcare Symposium